Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide screen to identify genetic loci associated with cognitive decline in late-life depression.

International psychogeriatrics·2025

Same author

Genome-wide screen to identify genetic loci associated with cognitive decline in late-life depression.

International psychogeriatrics·2020

Same author

Age, burnout and physical and psychological work ability among nurses.

Occupational medicine (Oxford, England)·2018

Same author

Effects of early life stress on depression, cognitive performance and brain morphology.

Psychological medicine·2016

Same author

Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function.

Genes, brain, and behavior·2012

Same author

A functional alternative splicing mutation in human tryptophan hydroxylase-2.

Molecular psychiatry·2010

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Geriatric depression and cognitive impairment.

D C Steffens¹, G G Potter

¹Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. steff001@mc.duke.edu

Psychological Medicine

|June 26, 2007

Summary

Geriatric depression often includes cognitive impairment, increasing risks for adverse outcomes. Proactive treatment combining medication and therapy can improve results for older adults with depression and cognitive issues.

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jul 14, 2026

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

Geriatric Psychiatry
Neuroscience
Clinical Psychology

Background:

Cognitive impairment frequently co-occurs with geriatric depression.
This co-occurrence elevates the risk of adverse medical, psychiatric, and cognitive outcomes in older adults.
Understanding this relationship is crucial for effective clinical management.

Purpose of the Study:

To review the clinical criteria and prevalence of depression and co-morbid cognitive impairment in the elderly.
To discuss factors contributing to persistent cognitive impairment in depressed individuals, including dementia.
To examine current research on assessing and treating cognitive impairment and dementia in the context of geriatric depression.

Main Methods:

Literature review of current research on depression and cognition in older adults.
Analysis of clinical criteria and prevalence data for depression and cognitive impairment.
Synthesis of findings related to risk factors, assessment, and treatment strategies.

Main Results:

Depression in older adults is often accompanied by cognitive impairment, leading to poorer health outcomes.
Factors influencing persistent cognitive impairment in depression include dementia and other underlying conditions.
Evidence supports integrated treatment approaches for managing both depression and cognitive decline.

Conclusions:

Current research provides valuable insights for clinical decision-making to mitigate adverse outcomes in geriatric depression with cognitive impairment.
Proactive management strategies are essential for this patient population.
Combined pharmacological and psychotherapeutic interventions show promise for improving patient prognosis.